Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T08:14:47.020Z Has data issue: false hasContentIssue false
  • English
  • Français

Away from Exploitation and towards Engagement: An Ethical Compass for Medical Researchers Working in Resource-Poor Countries

Published online by Cambridge University Press:  01 January 2021

Daniel W. Fitzgerald  and
Angela Wasunna
Get access Rights & Permissions [Opens in a new window]

Extract

In this era of globalization, as the health problems of poor countries and rich countries become increasingly intertwined, medical research is being conducted at the international level. For example, a research study may be sponsored by a developed country and conducted in a resource-poor country to address health problems faced by both nations. The globalization of medical research is, in effect, quickly outpacing the development of internationally accepted ethical guidelines for the conduct of research. For many medical researchers working in resource-poor countries, ethical decision-making is like sailing in the days before modern navigation; one is never quite sure where one is, or in what direction one is headed. Our aim in this article is to fix a few navigational points on an ethical compass to guide biomedical researchers from developed countries working in resource-poor countries.

Just as one of the principles underlying the Hippocratic Oath is “First, do no harm,” a principle underlying medical research ethics may be “First, do not exploit.”

Type
Article
Information
Journal of Law, Medicine & Ethics , Volume 33 , Issue 3 , Fall 2005 , pp. 559 - 565
Copyright
Copyright © American Society of Law, Medicine and Ethics 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Office of Inspector General, Department of Health and Human Services USA, “The Globalization of Clinical Trials,” 2001 OEI 01-00-00190.Google Scholar
Marshall, P. A., “The Relevance of Culture for Informed Consent in U.S. – funded International Health Research,” Commissioned Paper, National Bioethics Advisory Commission, Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries, vol. 2 (Bethesda: US Dept of Commerce, Technology Administration, National Technical Information Service, 2001).Google Scholar
“The Nuremberg Code,” Trials of War Criminals before the Military Tribunals under Control Council Law 10, vol 2 (Washington, DC: US Government Printing Office, 1949): 181–182.Google Scholar
The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report (Washington, DC: US Government Printing Offices, 1978).Google Scholar
World Medical Association (WMA), The Declaration of Helsinki, October 2000, available at <www.wma.net> (last visited June 13, 2005).+(last+visited+June+13,+2005).>Google Scholar
Carling, A., “Exploitation,” Encyclopedia of Applied Ethics, vol. 2 (New York: Academic Press, 1998): 219–232; Arneson, R., “Exploitation,” in Becker, L. C. Becker, C. B., eds., Encyclopedia of Ethics (New York: Garland Publishing, 1992): 350–352.Google Scholar
Roemer, J. E., A General Theory of Exploitation and Class (Cambridge: Harvard University Press, 1982).CrossRefGoogle Scholar
The Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries, Moral Standards for Research in Developing Countries, “From ‘Reasonable Availability’ to ‘Fair Benefits,’” Hastings Center Report 34 (2004): 17–27.Google Scholar
Nuffield Council on Bioethics, The Ethics of Research Related to Health Care in Developing Countries, available at <www.nuffieldbioethics.org/publications> (last visited June 13, 2005).+(last+visited+June+13,+2005).>Google Scholar
Office of Inspector General, Department of Health and Human Services USA, Recruiting Human Subjects: Pressures in Industry Sponsored Clinical Research, 2000. OEI-01-97-00195.Google Scholar
Kass, N. Hyder, A. A., “Attitudes and Experiences of US and Developing Country Investigators Regarding US Human Subjects Regulations,” Commissioned Paper, National Bioethics Advisory Commission, Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries, vol. 2 (Bethesda: US Dept of Commerce, Technology Administration, National Technical Information Service, 2001).Google Scholar
Council for International Organizations of Medical Sciences (CIOMS), “International Ethical Guidelines for Biomedical Research Involving Human Subjects” (CIOMS: Geneva, 2002) at <http://www.cioms.ch/frame_guidelines_nov_2002.htm> (last visited June 17, 2005).+(last+visited+June+17,+2005).>Google Scholar
UNAIDS guidance document, Ethical Considerations in HIV Preventive Vaccine Research, June 1991, at <www.unaids.org/publications/documents> (last visited June 13, 2005); Guenter, D. Esparza, J. Macklin, R., “Ethical Considerations in International HIV Vaccine Trials: Summary of a Consultative Process Conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS),” Journal of Medical Ethics 26 (2000): 37–43.CrossRefGoogle Scholar
Commission on Health Research for Development, Health Research: Essential Link to Equity in Development (Oxford: Oxford University Press, 1990); Benatar, S. R. Singer, P. A., “Beyond Helsinki: A Vision for Global Health Ethics,” British Medical Journal 322 (2001): 747–748.Google Scholar
Nielsen, K., “Global Justice, Capitalism and the Third World,” in Attfield, R. Wilkin, B., eds., International Justice and the Third World (London, New York: Routledge, 1992): At 28.Google Scholar
Rawls, J., Theory of Justice (Cambridge, MA: Harvard University Press, 1971).Google Scholar
Beitz, C. R., “Justice and International Relations,” in Blocker, H. G. Smith, E. H., eds., John Rawls' Theory of Social Justice: An Introduction (Athens: Ohio University Press, 1980): At 232.Google Scholar
Lavery, J. V., “Putting International Research Ethics Guidelines to Work for the Benefit of Developing Countries,” Yale Journal of Health Policy, Law and Ethics IV (2004): At 335.Google Scholar
The Centers for Disease Control and Prevention, Syphilis Elimination: History in the Making, 2003, at <http://www.cdc.gov/stopsyphilis>..>Google Scholar
Radolf, J. D. Sanchez, P. J. Schulz, K. F. Murphy, F. K., “Congenital Syphilis,” in Holmes, K. K. Mardh, P. Sparling, P. F. Lemon, S. M. Stamm, W. E. Piot, P. Wasserheit, J. N., eds., Sexually Transmitted Diseases (New York: McGraw Hill, 1999): 1168–1170.Google Scholar
Fitzgerald, D. W. Behets, F. M., “A Piece of my Mind: Beyond Folklore,” JAMA 288 (2002): At 2791–2.Google Scholar
Benatar, S. R. Singer, P. A., “Beyond Helsinki: A Vision for Global Health Ethics,” British Medical Journal 322 (2001): 747–748.Google Scholar
Kolata, G., “Companies Facing Ethical Issue as Drugs Are Tested Overseas,” New York Times, March 5, 2004, at 1.Google Scholar
The Centers for Disease Control and Prevention, “Update: Outbreak of Poliomyelitis – Dominican Republic and Haiti 2000–2001,” JAMA 286 (2001): At 2802.Google Scholar
Fitzgerald, D. W. Pape, J. W. Wasserheit, J. N. Counts, G. W. Corey, L., “Provision of Treatment in HIV-1 Vaccine Trials in Developing Countries,” Lancet 362 (2003): 993–994.CrossRefGoogle Scholar
UNAIDS, Epidemiological fact sheet, at <http://www.unaids.org/en/resources/epidemiology.asp> (last visited June 15, 2005).+(last+visited+June+15,+2005).>Google Scholar
See for example, the current controversies over Tenofovir prophylactic research. Editorial, “The Trials of Tenofovir Trials,” Lancet 365 (2005): At 1111.Google Scholar
Gupta, R. Cegielski, P. Espinal, M. A. Henkens, M. Kim, J. Y. Lambregts-Van Weezenbeek, C. S. B. Lee, J. Raviglione, M. C. Suarez, P. G. Varaine, F., “Increasing Transparency in Partnership for Health-introducing the Green Light Committee,” Tropical Medicine and International Health 7 (2002): 970–976.CrossRefGoogle Scholar
Mrazek, M. F. Mossialos, E., “Stimulating Pharmaceutical Research and Development for Neglected Diseases,” Health Policy 64 (2002): At 75–88.CrossRefGoogle Scholar
Gumucio Dagron, A., Making Waves: Stories of Participatory Communication for Social Change (New York: Rockefeller Foundation, 2001): 5–37.Google Scholar
National Bioethics Advisory Commission, Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries, vol. 1 (Bethesda: US Dept of Commerce, Technology Administration, National Technical Information Service, 2001).Google Scholar
Anand, S. Diderichsen, F. Evans, T. Schkolnikov, V. M. Wirth, M., “Measuring Disparities in Health: Methods and Indicators,” in Evans, T. Whitehead, M. Diderichsen, F. Bhuiya, A. Wirth, M., eds., Challenging Inequities in Health: From Ethics to Action (New York: Oxford Press, 2001): 48–68.CrossRefGoogle Scholar